Fenofibrate strengths are not interchangeable milligram for milligram, and M Care sources tablets and capsules matched to the exact reference formulation your dossier requires.

Fenofibrate formulations use different particle-size technology (micronized versus nanocrystallized) to reach the same fenofibric acid blood level, so the milligram figure alone does not indicate equivalence. A 145mg nanocrystallized tablet and a 160mg micronized tablet can be clinically comparable, but a straight substitution without checking the reference formulation is not safe practice for a dossier or a tender specification.

Those strengths, carried under the brand Adilip, follow the strength convention used for choline fenofibrate (fenofibric acid), a related but distinct active pharmaceutical ingredient from fenofibrate, rather than the 145mg, 160mg and 200mg fenofibrate convention described above. M Care confirms the exact salt against the certificate of analysis and states it on the proforma invoice before this line is registered with a regulator or offered against any other strength in this catalogue, so it should never be assumed interchangeable with a fenofibrate-labelled specification without that confirmation.

No. M Care is a merchant-exporter, not a manufacturer, and does not hold WHO-GMP or WHO-PQ certification itself. Fenofibrate lines are sourced from WHO-GMP certified Indian manufacturers, and the manufacturer's GMP certificate and site documentation can be passed through to buyers on request. M Care's own credentials are ISO 9001:2015 and a CDSCO export licence.

M Care's fenofibrate catalogue is oral tablets and capsules only, across 33 lines. Most lines are labelled 145mg, 160mg or 200mg; one brand line is listed at 45mg and 135mg following the fenofibric acid convention, with the exact salt confirmed before dispatch (see above). M Care does not stock fenofibrate injection, oral suspension, or any topical, ophthalmic, inhaled or sachet form; these formats are not part of the current line list and no availability claim is made for them.

Name the exact strength, dosage form and product line, not just fenofibrate and a milligram figure. Because M Care's catalogue spans more than one strength convention, including the fenofibric acid convention at 45mg and 135mg, the purchase order should reference the specific reference formulation the buyer's marketing authorisation or tender document already cites and request salt confirmation on the proforma invoice where relevant, so the shipped line bridges correctly.

Fenofibrate is contraindicated in severe renal impairment, including dialysis, in active or hepatic liver disease including primary biliary cirrhosis and unexplained persistent liver function abnormality, and in preexisting gallbladder disease, and can cause a reversible rise in serum creatinine during use. These are prescribing and monitoring considerations for the importer's own regulatory and clinical teams; M Care does not provide patient-level dosing guidance.

Each batch ships with a certificate of analysis specific to that batch, a certificate of pharmaceutical product or free sale certificate as the destination regulator requires, and stability data for the solid oral dosage form. Manufacturer GMP certification is available on request to support the importer's own registration file.